#SALES #GROWTH 5 Year CAGR 23.9%
Revenue during FY24 stood at โน9,822 cr, up by 17.6%. The TCV grew by 13% to $1,829 mn in FY24, out of which new deals increased by 19% to $1,130 mn. Despite a weaker demand environment coupled with higher furloughs, the growth was robust due to uptick in existing as well as new client accounts, deal ramp ups along with a healthy deal pipeline, increased efficiency and higher employee utilisation. The growth was broad-based across verticals & geographies. Healthcare is leading the growth followed by BFSI & Technology. Revenue in 9M FY25 was โน8,697 cr, up by 20%. TCV in 9M stood at $1,586 mn, higher by 15% YoY. Out of this, new TCV was $1,034 mn, up by 25% YoY. During Q3 FY25, they won their highest ever deal of $150 mn with tenure of 7 years from a US-based financial service company. The growth was broad based across verticals & regions led by Healthcare, North America & RoW. Client growth was robust across buckets.
Revenue during FY24 stood at โน9,822 cr, up by 17.6%. The TCV grew by 13% to $1,829 mn in FY24, out of which new deals increased by 19% to $1,130 mn. Despite a weaker demand environment coupled with higher furloughs, the growth was robust due to uptick in existing as well as new client accounts, deal ramp ups along with a healthy deal pipeline, increased efficiency and higher employee utilisation. The growth was broad-based across verticals & geographies. Healthcare is leading the growth followed by BFSI & Technology. Revenue in 9M FY25 was โน8,697 cr, up by 20%. TCV in 9M stood at $1,586 mn, higher by 15% YoY. Out of this, new TCV was $1,034 mn, up by 25% YoY. During Q3 FY25, they won their highest ever deal of $150 mn with tenure of 7 years from a US-based financial service company. The growth was broad based across verticals & regions led by Healthcare, North America & RoW. Client growth was robust across buckets.
๐3๐2๐ฅ1๐ซก1
#EBITDA #GROWTH 5 Year CAGR 24.7%
EBITDA during FY24 was โน1,676 cr, up by 10% YoY. Employee costs were higher by ~20% as the company continued to invest in freshers. The sub-contracting costs were up by 10%, due to the initial ramp up of certain large deals, which led to the onsite effort rise. Despite these, profitability was higher as revenue growth was strong along with increased utilisation and efficiency. EBITDA stood at โน1,474 cr in 9M FY25, up by 21% YoY. Employee costs were higher by 14% YoY while cost of professionals were higher by 63% due to uptick in onsite resources owing to ramp up of a healthcare deal. Other expenses were higher by 11% YoY.
EBITDA during FY24 was โน1,676 cr, up by 10% YoY. Employee costs were higher by ~20% as the company continued to invest in freshers. The sub-contracting costs were up by 10%, due to the initial ramp up of certain large deals, which led to the onsite effort rise. Despite these, profitability was higher as revenue growth was strong along with increased utilisation and efficiency. EBITDA stood at โน1,474 cr in 9M FY25, up by 21% YoY. Employee costs were higher by 14% YoY while cost of professionals were higher by 63% due to uptick in onsite resources owing to ramp up of a healthcare deal. Other expenses were higher by 11% YoY.
โก2๐ฅ1๐1
#PAT #GROWTH 5 Year CAGR 25.5%
PAT stood at โน1,093 cr, up by 19% YoY. Finance costs reduced by 1% due to lower borrowings, while depreciation expenses were up by 14%, due to higher facilities. Other income were higher by ~82%. Higher revenue growth & income and cost optimization helped offset the higher expenses leading to strong growth in profits. Forex gain during the year was โน8.5 cr as compared to a loss of โน13.3 cr. PAT in 9M FY25 stood at โน1,004 cr, an increase of 29% over 9M FY24. Finance costs were higher by 32% YoY while depreciation decreased by 1% during the same period. Other income was higher by 23% YoY at โน120 cr during 9M FY25. Other income included one-time gain of ~โน8 cr in Q2 FY25 owing to gain on closures of the Pune & Indore facilities. The forex gain during 9M FY25 was ~โน24 cr v/s โน10 cr in 9M FY24.
PAT stood at โน1,093 cr, up by 19% YoY. Finance costs reduced by 1% due to lower borrowings, while depreciation expenses were up by 14%, due to higher facilities. Other income were higher by ~82%. Higher revenue growth & income and cost optimization helped offset the higher expenses leading to strong growth in profits. Forex gain during the year was โน8.5 cr as compared to a loss of โน13.3 cr. PAT in 9M FY25 stood at โน1,004 cr, an increase of 29% over 9M FY24. Finance costs were higher by 32% YoY while depreciation decreased by 1% during the same period. Other income was higher by 23% YoY at โน120 cr during 9M FY25. Other income included one-time gain of ~โน8 cr in Q2 FY25 owing to gain on closures of the Pune & Indore facilities. The forex gain during 9M FY25 was ~โน24 cr v/s โน10 cr in 9M FY24.
๐ฅ2๐1๐1๐ฆ1
#EBITDA #MARGIN
EBITDA margin in FY24 stood at 17.1% as compared to 18.2% in FY23. One-time costs due to the transitioning of ramp up of multiple large deals, higher onsite mix, higher travel costs, wage hikes all led to impact on the margins. In 9M FY25, EBITDA margin stood at 16.9%, flat YoY. One-time visa costs, higher SG&A (selling, general & administrative costs), wage hikes, ESOP costs, lower earn-out reversals, had negative impact on margins. These headwinds were offset by right shoring, pricing, increased utilization, operational efficiencies, and forex.
EBITDA margin in FY24 stood at 17.1% as compared to 18.2% in FY23. One-time costs due to the transitioning of ramp up of multiple large deals, higher onsite mix, higher travel costs, wage hikes all led to impact on the margins. In 9M FY25, EBITDA margin stood at 16.9%, flat YoY. One-time visa costs, higher SG&A (selling, general & administrative costs), wage hikes, ESOP costs, lower earn-out reversals, had negative impact on margins. These headwinds were offset by right shoring, pricing, increased utilization, operational efficiencies, and forex.
โก2๐ฅ2๐1
#PAT #MARGIN
The company recorded a PAT margin of 11.1% in FY24 as compared to 11% in FY23. The margins were slightly up due to lower finance costs and higher other income. PAT margin stood at 11.5%, up by 80 bps YoY. The company was able to modestly sustain margins backed by revenue growth, higher other income along with lower depreciation costs
The company recorded a PAT margin of 11.1% in FY24 as compared to 11% in FY23. The margins were slightly up due to lower finance costs and higher other income. PAT margin stood at 11.5%, up by 80 bps YoY. The company was able to modestly sustain margins backed by revenue growth, higher other income along with lower depreciation costs
๐3โก1๐1
#ROCE
ROCE for FY24 was 31.26%. PBIT during the year stood at โน1,494 cr, while capital employed stood at โน5,054 cr. It increased majorly due to higher current assets.
ROCE for FY24 was 31.26%. PBIT during the year stood at โน1,494 cr, while capital employed stood at โน5,054 cr. It increased majorly due to higher current assets.
โก2โค1๐ฅ1๐ซก1
#ROE
In FY24, the ratio stood at 25.86%. Net profit increased to โน1,093.5 cr, while the net worth stood at โน4,957.7 cr. Net worth increased majorly due to higher profits.
In FY24, the ratio stood at 25.86%. Net profit increased to โน1,093.5 cr, while the net worth stood at โน4,957.7 cr. Net worth increased majorly due to higher profits.
๐ฅ2๐1๐1
#Company #potential
โข According to the Future of technology Servicesโ Winning in this Decade, published by NASSCOM, Indian technologies services industry is forecasted to grow 10%-12% to reach $300-$350 bn revenue and share of digital in Indian technology services revenue is likely to be 55%-60% by 2025 with an annual growth of 25%-30%. โข The average tech spending of global enterprises stood at 3% of their revenue which is expected to move to 5% of revenue by 2030. By FY26, ~51% of IT spending is expected to shift from traditional solutions to public cloud as compared to 41% in FY23. โข India is the topmost off-shoring destination for IT companies across the world. Having proven its capabilities in delivering both onshore and off-shore services to global clients, emerging technologies now offer an entire new gamut of opportunities for top IT firms in India. grow exponentially in the near future. โข The country's cost competitiveness in providing IT services, which is approximately 3-4 times more cost-effective than the US, continues to be its unique selling proposition in the global sourcing market. โข Companies are actively exploring opportunities for digitization, leading to increased demand for consulting services. Digital technologies and next-generation technologies such as 5G, AI/ Intelligent Enterprise, robotics and blockchain, are anticipated to โข Cloud technology is a priority for majority of the organizations, while cyber-security concerns are at the top of mind of CEOs. AI, automation, data analytics, IoT and robotics will be the key drivers of the future tech stack.
โข According to the Future of technology Servicesโ Winning in this Decade, published by NASSCOM, Indian technologies services industry is forecasted to grow 10%-12% to reach $300-$350 bn revenue and share of digital in Indian technology services revenue is likely to be 55%-60% by 2025 with an annual growth of 25%-30%. โข The average tech spending of global enterprises stood at 3% of their revenue which is expected to move to 5% of revenue by 2030. By FY26, ~51% of IT spending is expected to shift from traditional solutions to public cloud as compared to 41% in FY23. โข India is the topmost off-shoring destination for IT companies across the world. Having proven its capabilities in delivering both onshore and off-shore services to global clients, emerging technologies now offer an entire new gamut of opportunities for top IT firms in India. grow exponentially in the near future. โข The country's cost competitiveness in providing IT services, which is approximately 3-4 times more cost-effective than the US, continues to be its unique selling proposition in the global sourcing market. โข Companies are actively exploring opportunities for digitization, leading to increased demand for consulting services. Digital technologies and next-generation technologies such as 5G, AI/ Intelligent Enterprise, robotics and blockchain, are anticipated to โข Cloud technology is a priority for majority of the organizations, while cyber-security concerns are at the top of mind of CEOs. AI, automation, data analytics, IoT and robotics will be the key drivers of the future tech stack.
๐1๐ฅ1๐1๐ซก1
#COMPANY #OUTLOOK
โข They aim to deliver a revenue of $2 billion by FY27 and $5 billion by FY31. Strategic levers around FY31 plans would be shared in the subsequent quarters. The company reiterated to raise their EBIT margins by ~200-300 bps by FY27 as the company scales up. Improving operational parameters like efficient utilization, better offshore & onshore mix and pricing would aid in boosting margins. โข In terms of segments, moving ahead, they expect majority growth from the healthcare space followed by BFSI and then Hi-Tech. โข The comfortable utilization rate ranges for the company would be ~83%-85%, going ahead. โข The company is confident of its growth on account of a healthy deal pipeline and no signs of weakness is anticipated. โข The company would focus on enhanced service offerings to drive revenue growth going ahead and cost optimization levers around employee costs & efficiency to drive margin expansion. This would lead to a healthy growth in the coming quarters. โข The medium-term margin levers would be efficient utilization rate, right shoring of employees, pace of higher investments normalizing which would lead to lower SG&A costs, sustained growth momentum, right pricing as well as differentiated offerings. Additionally, its platforms (SASVA & iAura) have higher margins and the uptick in those deals would aid margin expansion. โข The revenue target for FY31 would be driven by scaling up of the 3 core verticals, doubling down on the Top 100 customers that contribute ~80% to the companyโs revenue, expanding alternate channels like private equity & sourcing advisors and enhancing focus on global capability centres through infusion of digital capabilities and AI.
โข They aim to deliver a revenue of $2 billion by FY27 and $5 billion by FY31. Strategic levers around FY31 plans would be shared in the subsequent quarters. The company reiterated to raise their EBIT margins by ~200-300 bps by FY27 as the company scales up. Improving operational parameters like efficient utilization, better offshore & onshore mix and pricing would aid in boosting margins. โข In terms of segments, moving ahead, they expect majority growth from the healthcare space followed by BFSI and then Hi-Tech. โข The comfortable utilization rate ranges for the company would be ~83%-85%, going ahead. โข The company is confident of its growth on account of a healthy deal pipeline and no signs of weakness is anticipated. โข The company would focus on enhanced service offerings to drive revenue growth going ahead and cost optimization levers around employee costs & efficiency to drive margin expansion. This would lead to a healthy growth in the coming quarters. โข The medium-term margin levers would be efficient utilization rate, right shoring of employees, pace of higher investments normalizing which would lead to lower SG&A costs, sustained growth momentum, right pricing as well as differentiated offerings. Additionally, its platforms (SASVA & iAura) have higher margins and the uptick in those deals would aid margin expansion. โข The revenue target for FY31 would be driven by scaling up of the 3 core verticals, doubling down on the Top 100 customers that contribute ~80% to the companyโs revenue, expanding alternate channels like private equity & sourcing advisors and enhancing focus on global capability centres through infusion of digital capabilities and AI.
๐2โก1๐ฅ1๐1๐ซก1
Persistent Systems 4200-4890
Expected level 6000
Support 4000
Expected level 6000
Support 4000
โก4๐ฅ2
Trident company details report
Established in 1990, formerly known as Abhishek Industries Limited, the name was changed to Trident Limited in 2011 (a flagship group of Trident group). The company has a presence in over 150 countries around the world and has two subsidiaries. In 2016, they ventured into the bed linen business by launching a factory in Budni, Madhya Pradesh. Currently, the company has three manufacturing units: two in Barnala (Punjab) and one in Budni (Madhya Pradesh). The product portfolio includes- Yarn, Home textiles (Bath & Bed Linen) and paper & chemicals. They cater to all the segments of the market- brands, department stores, home specialty chains, mass merchants and institutional customers and perform under three verticals: loyalty business, supermarket/hypermarket business and hospitality business. Their major marquee customers includes Walmart, D-mart, Ikea, Myntra, Amazon and Flipkart. The company established a foothold in the domestic and international markets through multi-brand shops and the โshop-in-shopโ concept.
Established in 1990, formerly known as Abhishek Industries Limited, the name was changed to Trident Limited in 2011 (a flagship group of Trident group). The company has a presence in over 150 countries around the world and has two subsidiaries. In 2016, they ventured into the bed linen business by launching a factory in Budni, Madhya Pradesh. Currently, the company has three manufacturing units: two in Barnala (Punjab) and one in Budni (Madhya Pradesh). The product portfolio includes- Yarn, Home textiles (Bath & Bed Linen) and paper & chemicals. They cater to all the segments of the market- brands, department stores, home specialty chains, mass merchants and institutional customers and perform under three verticals: loyalty business, supermarket/hypermarket business and hospitality business. Their major marquee customers includes Walmart, D-mart, Ikea, Myntra, Amazon and Flipkart. The company established a foothold in the domestic and international markets through multi-brand shops and the โshop-in-shopโ concept.
๐ฅ4โก1โค1๐ซก1
#SALES #GROWTH
In FY24, sales stood at โน6,809 cr, a growth of ~8% YoY, primarily owing to increase in the demand across segments. On the revenue front, Yarn and hometextile witnessed a rise, contributing ~83% of the total revenue, driven by higher capacity utilization while Paper & Chemicals witnessed a decline in the same. However, the year witnessed increased exports YoY (61% in FY24), that have helped the segment gain traction. In 9M FY25, sales declined by ~0.1% YoY to โน5,123 cr. On the revenue front, Yarn and Bed-linen grew by ~15% and ~3% YoY to โน2,704 cr and โน1,023 cr, respectively. While the Bath-linen and Paper & Chemical segment observed a decline of ~7% and ~15% to โน1,877 cr and โน740 cr, respectively. Exports for 9M FY25 was ~โน3,088 cr v/s ~โน3,207 cr, showcasing a decline of ~4% YoY.
In FY24, sales stood at โน6,809 cr, a growth of ~8% YoY, primarily owing to increase in the demand across segments. On the revenue front, Yarn and hometextile witnessed a rise, contributing ~83% of the total revenue, driven by higher capacity utilization while Paper & Chemicals witnessed a decline in the same. However, the year witnessed increased exports YoY (61% in FY24), that have helped the segment gain traction. In 9M FY25, sales declined by ~0.1% YoY to โน5,123 cr. On the revenue front, Yarn and Bed-linen grew by ~15% and ~3% YoY to โน2,704 cr and โน1,023 cr, respectively. While the Bath-linen and Paper & Chemical segment observed a decline of ~7% and ~15% to โน1,877 cr and โน740 cr, respectively. Exports for 9M FY25 was ~โน3,088 cr v/s ~โน3,207 cr, showcasing a decline of ~4% YoY.
๐ฅ2โก1๐1๐1๐ซก1
#EBITDA #GROWTH
In FY24, EBITDA declined by ~2% YoY to โน928 cr. Company observed decline in the same owing to an uptrend in key raw material prices (cotton, yarn, dyes & chemicals and agro-based products) and increase in other expenses. Textiles observed price pressure due to subdued cotton prices, whereas paper prices were under pressure due to heavy imports. Major expenses for the company constituted cost of materials consumed 51% , employee benefit expense 13% and other expenses (majorly towards power & fuel and packing materials consumed) 23%. In 9M FY25, EBITDA declined by ~11% YoY to โน648 cr. During the period, employee benefit expense witnessed a rise YoY.
In FY24, EBITDA declined by ~2% YoY to โน928 cr. Company observed decline in the same owing to an uptrend in key raw material prices (cotton, yarn, dyes & chemicals and agro-based products) and increase in other expenses. Textiles observed price pressure due to subdued cotton prices, whereas paper prices were under pressure due to heavy imports. Major expenses for the company constituted cost of materials consumed 51% , employee benefit expense 13% and other expenses (majorly towards power & fuel and packing materials consumed) 23%. In 9M FY25, EBITDA declined by ~11% YoY to โน648 cr. During the period, employee benefit expense witnessed a rise YoY.
๐ฅ3๐2โก1๐ซก1
#PAT #GROWTH
In FY24, PAT declined by ~21% YoY to โน350 cr. This was due to a contraction in the operating profit. Other income rose significantly during the period, largely due to rising interest income towards bank deposits. In 9M FY25, PAT declined by ~18% YoY to โน237 cr, led by declining operating profit. The company is focusing on enhancing production capacities by venturing into new markets through different mediums domestically and globally. The growing acceptance of the brands demonstrates healthy potential to address opportunities, going forward.
In FY24, PAT declined by ~21% YoY to โน350 cr. This was due to a contraction in the operating profit. Other income rose significantly during the period, largely due to rising interest income towards bank deposits. In 9M FY25, PAT declined by ~18% YoY to โน237 cr, led by declining operating profit. The company is focusing on enhancing production capacities by venturing into new markets through different mediums domestically and globally. The growing acceptance of the brands demonstrates healthy potential to address opportunities, going forward.
โก2๐2๐ฅ1๐ซก1
#EBITDA #MARGIN
In FY24, EBITDA margin contracted by 129 bps YoY to ~14%, mainly affected due to high input costs in both textile and paper business. The major raw materials used by the company includes cotton and wheat straw. In 9M FY25, EBITDA margin contracted by ~152 bps YoY to 12.7%, due to rising input costs. As a percentage of revenue, employee benefit expenses witnessed an expansion during the period. Segment-wise, EBIT margin during 9M FY25 for Paper & Chemicals was 27.2% (v/s 25.4% in 9M FY24), Bed-linen 16.3% (v/s 18.7% in 9M FY24), Bathlinen 5.2% (v/s 5.7% in 9M FY24) and Yarn was 4.5% (v/s 3.1% in 9M FY24).
In FY24, EBITDA margin contracted by 129 bps YoY to ~14%, mainly affected due to high input costs in both textile and paper business. The major raw materials used by the company includes cotton and wheat straw. In 9M FY25, EBITDA margin contracted by ~152 bps YoY to 12.7%, due to rising input costs. As a percentage of revenue, employee benefit expenses witnessed an expansion during the period. Segment-wise, EBIT margin during 9M FY25 for Paper & Chemicals was 27.2% (v/s 25.4% in 9M FY24), Bed-linen 16.3% (v/s 18.7% in 9M FY24), Bathlinen 5.2% (v/s 5.7% in 9M FY24) and Yarn was 4.5% (v/s 3.1% in 9M FY24).
โค1โก1๐1๐ฅ1๐1